Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)

Market Cap	2.01B -1.4%
Revenue (ttm)	735.18M -15.8%
Net Income	8.42M -79.4%
EPS	0.04 -80.5%
Shares Out	235.30M
PE Ratio	239.34
Forward PE	n/a
Dividend	0.03 (0.34%)
Ex-Dividend Date	May 27, 2026

Volume	7,364,226
Open	8.73
Previous Close	8.86
Day's Range	8.50 - 8.91
52-Week Range	8.40 - 15.19
Beta	0.04
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 31, 2026

About SHE:002873

Guiyang Xintian Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of new traditional Chinese medicines in China. The company offers products in various dosage forms, including hard capsules, oral solutions, granules, gels, tablets, syrups, tinctures, lotions, medicated wines, and elixirs. Its products are used for the treatment of gynecological, urinary tract, breast, thyroid, cardiovascular, anti-tumor, and dental diseases, as well as for oral health; and cold, heat-clearing, an...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 1,388
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002873

Financial Performance

In 2025, SHE:002873's revenue was 749.72 million, a decrease of -12.57% compared to the previous year's 857.55 million. Earnings were 9.11 million, a decrease of -82.59%.